KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 292-294

  Bennett, Jason W ^a   Herrera, Monica L ^b   Lewis II, James S ^c,d   Wickes, Brian W ^c   Jorgensen, James H ^b,c  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIFUNGAL AGENT; BACTERIAL ENZYME; CARBAPENEMASE; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; KPC 2 ENZYME; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CASE REPORT; CRITICALLY ILL PATIENT; DISEASE COURSE; ENTEROBACTER CLOACAE; FEMALE; GRAFT INFECTION; HUMAN; HUMAN TISSUE; LIVER GRAFT; MIXED INFECTION; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ENTEROBACTER CLOACAE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS PUTIDA; RNA, RIBOSOMAL, 16S;

EID: 59749105224     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00931-08     Document Type: Article

References (15)

1. Almuzara, M., M. Radice, N. de Gárate, A. Kossman, A. Cuirolo, G. Santella, A. Famiglietti, G. Gutkind, and V. Vay. 2007. VIM-2-producing Pseudomonas putida, Buenos Aires. Emerg. Infect. Dis. 13:668-669.
2. Anderson, K. F., D. R. Lonsway, J. K. Rasheed, J. Biddle, B. Jensen, L. K. McDougal, R. B. Carey, A. Thompson, S. Stocker, B. Limbago, and J. B. Patel. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725.
3. Boagaerts, P., T. Huang, H. Rodriguez-Villalobos, C. Bauraing, A. Deplano, M. J. Struelens, and Y. Glupczynski. 2008. Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-β-lactamases. J. Antimicrob. Chemother. 61:749-751.
4. Carpenter, R. J., J. D. Hartzell, J. A. Forsberg, B. S. Babel, and A. Ganesan. 2008. Pseudomonas putida war wound infection in a US marine: a case report and review of the literature. J. Infect. 56:234-240.
5. Castanheira, M., H. S. Sader, L. M. Deshpande, T. R. Fritsche, and R. N. Jones. 2008. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing Enterobacteriaceae: report form the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 52:570-573.
6. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. Approved standard M100-S18. CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. CLSI, Wayne, PA.
8. Horii, T., H. Muramatsu, and Y. Iinuma. 2005. Mechanisms of resistance to fluoroquinolones and carbapenems in Pseudomonas putida. J. Antimicrob. Chemother. 56:643-647.
9. Lewis, J. S., II, M. Herrera, B. Wickes, J. E. Patterson, and J. H. Jorgensen. 2007. First report of the emergence of CTX-M-type extended spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021.
10. imp-1 and a new aminoglycoside resistance gene, aac(6′)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob. Agents Chemother. 51:2611-2614.
11. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
12. Rasheed, J. K., J. W. Biddle, K. F. Anderson, L. Waisher, C. Chenoweth, J. Perrin, D. W. Newton, and J. B. Patel. 2008. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J. Clin. Microbiol. 46:2066-2069.
13. Tibbetts, R., J. G. Frye, J. Marschall, D. Warren, and W. Dunne. 2008. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J. Clin. Microbiol. 46:3080-3083.
14. Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, J. P. Quinn, et al. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553-1555.
15. Watanabe, K., Y. Kodama, and S. Harayama. 2001. Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting. J. Microbiol. Methods 44:253-262.